MetaboliQs - A better diagnostic of cardiovascular diseases with diamond

The diamond material with NV centers enable a better quality of cardiac imaging.
© Fotolia - Sebastian Kaulitzki
The diamond material with NV centers enable a better quality of cardiac imaging.

Cardiovascular diseases are one of the most common causes of death worldwide. Therefore, it is necessary to develop personalized medical solutions to improve the chances of curing patients. In order to do so, the metabolic process of heart tissue needs to be understood and observed on a molecular level. Current methods do not allow this in high resolution, and they furthermore rely on radioactive substances. Quantum technology offers a new approach: the project develops an innovative diamond polarizer that is able to work at room temperature with a 160-times higher efficiency, offering a polarization that is 40-times faster and 4-times cheaper than before. By those means, quantum technology is being utilized for human needs.

PROJEKTTITEL

MetaboliQs - Leveraging unparalleled room temperature quantum coherence to enable safe, first-of-its-kind, multimodal cardiac imaging

 

LAUFZEIT

2019 – 2021

FÖRDERMITTELGEBER

EU - FET Flagship on Quantum Technologies

KOORDINATOR

Fraunhofer IAF

ZIELE

  • Development and production of nanodiamonds with nitrogen vacancy centers for faster and better hyperpolarization
  • Development of a diamond based polarizer for preclinical experiments in the field of cardiovascular diseases
This research is receiving funding from the European Commission under grant agreement no. 820374.
This research is receiving funding from the European Commission under grant agreement no. 820374.

Further Information

 

Project Website

You can find more information about the project on the official website:  

 

News and events

Here you can find the latest news and events related to MetaboliQs: